TFA Therapeutics adopts new corporate name
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
TFA Therapeutics, Inc., formerly Cordyceps Sunshine Biotech Holdings Co., Ltd., reports that shareholders passed a special resolution on July 12, 2026 to change the company’s name to TFA Therapeutics, Inc. The certificate of incorporation on change of name was filed with the Cayman Islands Registry of Companies on July 20, 2026 and the completed certificate was received on July 22, 2026. The company’s ticker symbol remains unchanged.
Key Figures
Commission File Number: 333-269315
Shareholder resolution date: July 12, 2026
Cayman filing date: July 20, 2026
+1 more
4 metrics
Commission File Number
333-269315
Exchange Act registration reference for TFA Therapeutics, Inc.
Shareholder resolution date
July 12, 2026
Date shareholders approved the corporate name change by special resolution.
Cayman filing date
July 20, 2026
Date the certificate of incorporation on change of name was filed in the Cayman Islands.
Certificate receipt date
July 22, 2026
Date TFA Therapeutics, Inc. received the completed certificate of incorporation on change of name.
Key Terms
foreign private issuer, special resolution, Certificate of Incorporation on Change of Name, Registry of Companies, Cayman Islands
4 terms
foreign private issuer regulatory
"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
special resolution regulatory
"the shareholders ... passed a special resolution to change the Company’s name"
A special resolution is a formal shareholder vote that requires a higher-than-normal majority—typically around three-quarters—to approve major corporate changes, such as altering the company’s governing rules, selling the business, or winding it up. It matters to investors because it signals decisive, potentially value-altering actions that cannot be passed by a simple majority; think of it as needing extra votes to change the rules of a club, so minority interests are harder to override.
Certificate of Incorporation on Change of Name regulatory
"A copy of the Certificate of Incorporation on Change of Name is attached"
A certificate of incorporation on change of name is an official document issued by a government or corporate registrar that confirms a company has legally changed its registered name. Think of it like an updated birth certificate for a business; it matters to investors because it records the company's legal identity for contracts, stock records and regulatory filings, ensuring paperwork and ownership remain valid after the name change.
Registry of Companies, Cayman Islands regulatory
"completed the filing ... with the Registry of Companies, Cayman Islands"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What corporate change did TFA Therapeutics, Inc. (RAJAF) disclose?
TFA Therapeutics, Inc. disclosed that shareholders approved changing the company’s name from Cordyceps Sunshine Biotech Holdings Co., Ltd. to TFA Therapeutics, Inc. The change was formally recorded through a certificate of incorporation on change of name in the Cayman Islands.
When was the TFA Therapeutics, Inc. name change filed and confirmed?
The name change was filed with the Cayman Islands Registry of Companies on July 20, 2026, and TFA Therapeutics, Inc. received the completed certificate of incorporation on change of name on July 22, 2026, confirming the updated corporate name.
Did the ticker symbol for TFA Therapeutics, Inc. (RAJAF) change with the new name?
The company states that its ticker symbol remained unchanged following the corporate name change to TFA Therapeutics, Inc. Only the legal name was modified; the trading symbol associated with the company’s shares did not change.
Where is TFA Therapeutics, Inc. registered and what document evidences the name change?
TFA Therapeutics, Inc. is registered in the Cayman Islands, and the name change is evidenced by a Certificate of Incorporation on Change of Name filed with, and issued by, the Cayman Islands Registry of Companies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
